Inventor
WALLACE OWEN BRENDAN
US27 patents
⚠️ This page may combine multiple inventors who share the name “WALLACE OWEN BRENDAN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
LILLY CO ELI
16 patentsUS7968585B2Jun 28, 2011
Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
LILLY CO ELI7 citations83
US7119206B2Oct 10, 2006
Derivative of dihydro-dibenzo (a) anthracenes and their use as selective estrogen receptor modulators
LILLY CO ELI2 citations62
US6962928B2Nov 8, 2005
Tetrahydroquinoline derivatives for the inhibition of osteoporosis, estrogen dependent breast cancer, endometriosis and uterine fibrosis
LILLY CO ELI4 citations62
US7994176B2Aug 9, 2011
Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
LILLY CO ELI2 citations61
US7713979B2May 11, 2010
Cycloalkyl lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
LILLY CO ELI4 citations61
US7998999B2Aug 16, 2011
Cyclohexyl substituted pyrrolidinones as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
LILLY CO ELI3 citations60
US7829582B2Nov 9, 2010
Piperidinyl substituted pyrrolidinones as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
LILLY CO ELI1 citations51
US7375229B2May 20, 2008
Dihydro-dibenzo[B,E]oxepine based selective estrogen receptor modulators, compositions and methods
LILLY CO ELI0 citations51
US7271264B2Sep 18, 2007
Pentacyclic oxepines and derivatives thereof, compositions and methods
LILLY CO ELI0 citations51
US7067510B2Jun 27, 2006
Dihydro-dibenzo[b,e]oxepine based selective estrogren receptor modulators, compositions and methods
LILLY CO ELI0 citations51
US7056931B2Jun 6, 2006
2-substituted 1,2,3,4-tetrahydroquinolines and derivatives thereof, compositions and methods
LILLY CO ELI0 citations51
US7816349B2Oct 19, 2010
Substituted pyrrolidinones as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
LILLY CO ELI1 citations50
US7820659B2Oct 26, 2010
Cyclohexylimidiazole lactam derivatives as inhibitors of 11-β-hydroxysteroid dehydrogenase 1
LILLY CO ELI1 citations47
US7585977B2Sep 8, 2009
Selective estrogen receptor modulators containing a phenylsulfonyl group
LILLY CO ELI0 citations45
US7834194B2Nov 16, 2010
Cycloalkyl lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
LILLY CO ELI0 citations40
US7981918B2Jul 19, 2011
Cyclohexylpyrazole-lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
LILLY CO ELI0 citations39
FULCRUM THERAPEUTICS INC
7 patentsUS10973805B2Apr 13, 2021
Macrocyclic azolopyridine derivatives as EED and PRC2 modulators
FULCRUM THERAPEUTICS INC5 citations81
US11590111B2Feb 28, 2023
Macrocyclic azolopyridine derivatives as EED and PRC2 modulators
FULCRUM THERAPEUTICS INC2 citations70
US10537560B2Jan 21, 2020
P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD
FULCRUM THERAPEUTICS INC4 citations68
US10342786B2Jul 9, 2019
P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD
FULCRUM THERAPEUTICS INC4 citations68
US12109198B2Oct 8, 2024
Macrocyclic azolopyridine derivatives as EED and PRC2 modulators
FULCRUM THERAPEUTICS INC0 citations59
US11479770B2Oct 25, 2022
Use of p38 inhibitors to reduce expression of DUX4
FULCRUM THERAPEUTICS INC0 citations57
US11291659B2Apr 5, 2022
P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD
FULCRUM THERAPEUTICS INC0 citations57